Effect of Dexmedetomidine of Gastrointestinal Motility

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Anesthesia
Interventions
DRUG

Dexmedetomidine

Patients will undergo the usual anal manometry study, with no adjuvant medications, per routine practice currently in the gastrointestinal unit. Following completion of manometry, 0.5 mcg/kg DEX will be administered over 1 minute followed by an infusion of 0.15 mcg/kg/hr. Manometry measurements will be followed for 15 minutes in response to DEX.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT04798482 - Effect of Dexmedetomidine of Gastrointestinal Motility | Biotech Hunter | Biotech Hunter